Home > News > Nanogen Expands Molecular Diagnostic Product Menu
March 6th, 2003
Nanogen Expands Molecular Diagnostic Product Menu
Abstract:
Nanogen announced today that it has commercially released the first multiplex Analyte Specific Reagent, designed for the detection of Factor V Leiden and Factor II Prothrombin gene mutations associated with cardiovascular disease and the pathology of thrombosis.
Source:
Nanogen
| Related News Press |
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||